1,866
Views
54
CrossRef citations to date
0
Altmetric
Original Research

Sustained CD4+ T cell-driven lymphopenia without a compensatory IL-7/IL-15 response among high-grade glioma patients treated with radiation and temozolomide

, , , , , , & show all
Article: e27357 | Received 05 Nov 2013, Accepted 27 Nov 2013, Published online: 03 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Anna F. Piotrowski, Thomas R. Nirschl, Esteban Velarde, Lee Blosser, Sudipto Ganguly, Kathleen H. Burns, Leo Luznik, John Wong, Charles G. Drake & Stuart A. Grossman. (2018) Systemic depletion of lymphocytes following focal radiation to the brain in a murine model. OncoImmunology 7:7.
Read now
Tobias Weiss, Michael Weller & Patrick Roth. (2016) Immunological effects of chemotherapy and radiotherapy against brain tumors. Expert Review of Anticancer Therapy 16:10, pages 1087-1094.
Read now
Sara Pessina, Gabriele Cantini, Dimos Kapetis, Emanuela Cazzato, Natalia Di Ianni, Gaetano Finocchiaro & Serena Pellegatta. (2016) The multidrug-resistance transporter Abcc3 protects NK cells from chemotherapy in a murine model of malignant glioma. OncoImmunology 5:5.
Read now
Erika Vacchelli, Fernando Aranda, Alexander Eggermont, Catherine Sautès-Fridman, Eric Tartour, Eugene P Kennedy, Michael Platten, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial watch: IDO inhibitors in cancer therapy. OncoImmunology 3:10.
Read now

Articles from other publishers (50)

Ping Lin, Lingyan He, Nan Tian & Xuchen Qi. (2023) The evaluation of six genes combined value in glioma diagnosis and prognosis. Journal of Cancer Research and Clinical Oncology.
Crossref
Eun-Ki Min, Juhan Lee, Su Jin Jeong, Deok-Gie Kim, Seung Hyuk Yim, Mun Chae Choi, Dong Jin Joo, Myoung Soo Kim & Jae Geun Lee. (2023) Risk factors for late-onset Pneumocystis jirovecii pneumonia in liver transplant recipients. International Journal of Infectious Diseases 131, pages 166-172.
Crossref
Heng Chen, Zhonglong Liu, Kun Yue, Jiping Ding & Yue He. (2023) Immune microenvironment: novel perspectives on bone regeneration disorder in osteoradionecrosis of the jaws. Cell and Tissue Research 392:2, pages 413-430.
Crossref
François de Kermenguy, Lydia Meziani, Michele Mondini, Céline Clémenson, Daphné Morel, Eric Deutsch & Charlotte Robert. 2023. Ionizing Radiation and the Immune Response - Part B. Ionizing Radiation and the Immune Response - Part B 1 30 .
Elizabeth Smyth, Kelly Cozens, Daniel Griffiths, Kathryn L. Clark, Sean Ewings, Russell Petty, Tim Underwood, Rebecca C. Fitzgerald, James Tanner, Olivier Giger, Shubha Anand & Gareth Griffiths. (2022) ELEVATE – evaluating Temozolomide and Nivolumab in patients with advanced unresectable previously treated oesophagogastric adenocarcinoma with MGMT methylation: study protocol for a single arm phase II trial. BMC Cancer 22:1.
Crossref
Irma Telarovic, Carmen S.M. Yong, Matthias Guckenberger, Jan Unkelbach & Martin Pruschy. (2022) Radiation-induced lymphopenia does not impact treatment efficacy in a mouse tumor model. Neoplasia 31, pages 100812.
Crossref
Susannah G. Ellsworth & Stuart A. Grossman. 2022. Immunotherapeutic Strategies for the Treatment of Glioma. Immunotherapeutic Strategies for the Treatment of Glioma 1 17 .
Hwa Kyung Byun, Seung Yeun Chung, Kyoung-Jin Kim & Jinsil Seong. (2021) Role of Interleukin-7 in the Development of and Recovery from Radiation-Induced Lymphopenia: A Post-hoc Analysis of a Prospective Cohort. Cancer Research and Treatment 53:4, pages 962-972.
Crossref
Qin Wang, Shangbiao Li, Simiao Qiao, Zhihao Zheng, Xiaotong Duan & Xiaoxia Zhu. (2021) Changes in T Lymphocyte Subsets in Different Tumors Before and After Radiotherapy: A Meta-analysis. Frontiers in Immunology 12.
Crossref
David W. Andrews, Kevin D. Judy, Charles B. Scott, Samantha Garcia, Larry A. Harshyne, Lawrence Kenyon, Kiran Talekar, Adam Flanders, Kofi-Buaku Atsina, Lyndon Kim, Nina Martinez, Wenyin Shi, Maria Werner-Wasik, Haisong Liu, Mikhail Prosniak, Mark Curtis, Rhonda Kean, Donald Y. Ye, Emily Bongiorno, Sami Sauma, Mark A. Exley, Kara Pigott & D. Craig Hooper. (2021) Phase Ib Clinical Trial of IGV-001 for Patients with Newly Diagnosed Glioblastoma. Clinical Cancer Research 27:7, pages 1912-1922.
Crossref
Hwa Kyung Byun, Kyoung-Jin Kim, Su Chul Han & Jinsil Seong. (2021) Effect of Interleukin-7 on Radiation-Induced Lymphopenia and Its Antitumor Effects in a Mouse Model. International Journal of Radiation Oncology*Biology*Physics 109:5, pages 1559-1569.
Crossref
Catalina Lee-Chang, Jason Miska, David Hou, Aida Rashidi, Peng Zhang, Rachel A. Burga, Ignacio Jusué-Torres, Ting Xiao, Victor A. Arrieta, Daniel Y. Zhang, Aurora Lopez-Rosas, Yu Han, Adam M. Sonabend, Craig M. Horbinski, Roger Stupp, Irina V. Balyasnikova & Maciej S. Lesniak. (2021) Activation of 4-1BBL+ B cells with CD40 agonism and IFNγ elicits potent immunity against glioblastoma. Journal of Experimental Medicine 218:1.
Crossref
David Olayinka Kamson & Stuart Grossman. 2021. Neuro-Oncology for the Clinical Neurologist. Neuro-Oncology for the Clinical Neurologist 153 171 .
Antje Wick, Annick Desjardins, Cristina Suarez, Peter Forsyth, Ivelina Gueorguieva, Tiana Burkholder, Ann Louise Cleverly, Shawn T. Estrem, Shuaicheng Wang, Michael M. Lahn, Susan C. Guba, David Capper & Jordi Rodon. (2020) Phase 1b/2a study of galunisertib, a small molecule inhibitor of transforming growth factor-beta receptor I, in combination with standard temozolomide-based radiochemotherapy in patients with newly diagnosed malignant glioma. Investigational New Drugs 38:5, pages 1570-1579.
Crossref
Maryam Rahman, W Gregory Sawyer, Scott Lindhorst, Loic P Deleyrolle, Jeffrey K Harrison, Aida Karachi, Farhad Dastmalchi, Joseph Flores-Toro, Duane A Mitchell, Michael Lim, Mark R Gilbert & David A Reardon. (2020) Adult immuno-oncology: using past failures to inform the future. Neuro-Oncology 22:9, pages 1249-1261.
Crossref
Mathieu Cesaire, Brigitte Le Mauff, Audrey Rambeau, Olivier Toutirais & Juliette Thariat. (2020) Mécanismes de la lymphopénie radio-induite et implications thérapeutiques. Bulletin du Cancer 107:7-8, pages 813-822.
Crossref
Vaishali Kapoor, Andrea Collins, Kaylan Griffith, Subhajit Ghosh, Nathan Wong, Xiaowei Wang, Grant A. Challen, Joseph Krambs, Dan Link, Dennis E. Hallahan & Dinesh Thotala. (2020) Radiation induces iatrogenic immunosuppression by indirectly affecting hematopoiesis in bone marrow. Oncotarget 11:19, pages 1681-1690.
Crossref
Michael J. Gough, Shay Sharon, Marka R. Crittenden & Kristina H. Young. (2020) Using Preclinical Data to Design Combination Clinical Trials of Radiation Therapy and Immunotherapy. Seminars in Radiation Oncology 30:2, pages 158-172.
Crossref
Valérie Dutoit, Géraldine Philippin, Valérie Widmer, Eliana Marinari, Aurélie Vuilleumier, Denis Migliorini, Karl Schaller & Pierre-Yves Dietrich. (2020) Impact of Radiochemotherapy on Immune Cell Subtypes in High-Grade Glioma Patients. Frontiers in Oncology 10.
Crossref
Qianqian Zhao, Tingting Li, Gang Chen, Zhaochong Zeng & Jian He. (2020) Prognosis and Risk Factors of Radiation-Induced Lymphopenia in Early-Stage Lung Cancer Treated With Stereotactic Body Radiation Therapy. Frontiers in Oncology 9.
Crossref
Clemens Grassberger, Susannah G. Ellsworth, Moses Q. Wilks, Florence K. Keane & Jay S. Loeffler. (2019) Assessing the interactions between radiotherapy and antitumour immunity. Nature Reviews Clinical Oncology 16:12, pages 729-745.
Crossref
Hwa Kyung Byun, Nalee Kim, Sangjoon Park & Jinsil Seong. (2019) Acute severe lymphopenia by radiotherapy is associated with reduced overall survival in hepatocellular carcinomaAkute schwere Lymphopenie durch Strahlentherapie ist beim hepatozellulären Karzinom mit reduziertem Gesamtüberleben assoziiert. Strahlentherapie und Onkologie 195:11, pages 1007-1017.
Crossref
Lawrence Kleinberg, Lindsey Sloan, Stuart Grossman & Michael Lim. (2019) Radiotherapy, Lymphopenia, and Host Immune Capacity in Glioblastoma: A Potentially Actionable Toxicity Associated With Reduced Efficacy of Radiotherapy. Neurosurgery 85:4, pages 441-453.
Crossref
Woo Jin Kim, Yun-Sik Dho, Chan-Young Ock, Jin Wook Kim, Seung Hong Choi, Soon-Tae Lee, Il Han Kim, Tae Min Kim & Chul-Kee Park. (2019) Clinical observation of lymphopenia in patients with newly diagnosed glioblastoma. Journal of Neuro-Oncology 143:2, pages 321-328.
Crossref
Lu‐Lu Ye, Xing‐Wen Fan, Chao‐Su Hu, Xia‐Yun He, Xiao‐Shen Wang, Chun‐Ying Shen, Ting‐Ting Xu & Hong‐Mei Ying. (2019) Dosimetry of the brain and hypothalamus predicting acute lymphopenia and the survival of glioma patients with postoperative radiotherapy. Cancer Medicine 8:6, pages 2759-2768.
Crossref
Pavlina Chuntova, Kira M. Downey, Bindu Hegde, Neil D. Almeida & Hideho Okada. (2019) Genetically Engineered T-Cells for Malignant Glioma: Overcoming the Barriers to Effective Immunotherapy. Frontiers in Immunology 9.
Crossref
Aleksei Stepanenko & Vladimir Chekhonin. (2018) Recent Advances in Oncolytic Virotherapy and Immunotherapy for Glioblastoma: A Glimmer of Hope in the Search for an Effective Therapy?. Cancers 10:12, pages 492.
Crossref
Aida Karachi, Farhad Dastmalchi, Duane A Mitchell & Maryam Rahman. (2018) Temozolomide for immunomodulation in the treatment of glioblastoma. Neuro-Oncology 20:12, pages 1566-1572.
Crossref
Susannah G. Ellsworth. (2018) Field size effects on the risk and severity of treatment-induced lymphopenia in patients undergoing radiation therapy for solid tumors. Advances in Radiation Oncology 3:4, pages 512-519.
Crossref
Theresa Barberi, Allison Martin, Rahul Suresh, David J. Barakat, Sarah Harris-Bookman, Charles G. Drake, Michael Lim & Alan D. Friedman. (2018) Absence of host NF-κB p50 induces murine glioblastoma tumor regression, increases survival, and decreases T-cell induction of tumor-associated macrophage M2 polarization. Cancer Immunology, Immunotherapy 67:10, pages 1491-1503.
Crossref
Kalpana Mujoo, Clayton R. Hunt, Raj K. Pandita, Mauro Ferrari, Sunil Krishnan, John P. Cooke, Stephen Hahn & Tej K. Pandita. (2018) Harnessing and Optimizing the Interplay between Immunotherapy and Radiotherapy to Improve Survival Outcomes. Molecular Cancer Research 16:8, pages 1209-1214.
Crossref
Vassiliki A. Boussiotis & Alain Charest. (2017) Immunotherapies for malignant glioma. Oncogene 37:9, pages 1121-1141.
Crossref
Sandra Demaria, Sophia Bornstein & Silvia C. Formenti. 2018. Oncoimmunology. Oncoimmunology 507 524 .
Jian L. Campian, Anna F. Piotrowski, Xiaobu Ye, Frances T. Hakim, Jeremy Rose, Xiao-Yi Yan, Yao Lu, Ronald Gress & Stuart A. Grossman. (2017) Serial changes in lymphocyte subsets in patients with newly diagnosed high grade astrocytomas treated with standard radiation and temozolomide. Journal of Neuro-Oncology 135:2, pages 343-351.
Crossref
Richard E Kast, Quentin A Hill, Didier Wion, Håkan Mellstedt, Daniele Focosi, Georg Karpel-Massler, Tim Heiland & Marc-Eric Halatsch. (2017) Glioblastoma-synthesized G-CSF and GM-CSF contribute to growth and immunosuppression: Potential therapeutic benefit from dapsone, fenofibrate, and ribavirin. Tumor Biology 39:5, pages 101042831769979.
Crossref
Todd Crocenzi, Benjamin Cottam, Pippa Newell, Ronald F. Wolf, Paul D. Hansen, Chet Hammill, Matthew C. Solhjem, Yue-Yun To, Amy Greathouse, Garth Tormoen, Zeljka Jutric, Kristina Young, Keith S. Bahjat, Michael J. Gough & Marka R. Crittenden. (2016) A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borderline resectable and locally advanced pancreatic adenocarcinoma. Journal for ImmunoTherapy of Cancer 4:1.
Crossref
Neil M. D’Souza, Penny Fang, Jennifer Logan, Jinzhong Yang, Wen Jiang & Jing Li. (2016) Combining Radiation Therapy with Immune Checkpoint Blockade for Central Nervous System Malignancies. Frontiers in Oncology 6.
Crossref
A.Gabriella Wernicke, Andrew W. Smith, Shoshana Taube & Minesh P. Mehta. (2016) Glioblastoma: Radiation treatment margins, how small is large enough?. Practical Radiation Oncology 6:5, pages 298-305.
Crossref
Andrew W. Smith, Minesh P. Mehta & A. Gabriella Wernicke. (2016) Neural stem cells, the subventricular zone and radiotherapy: implications for treating glioblastoma. Journal of Neuro-Oncology 128:2, pages 207-216.
Crossref
Christopher M. Jackson, Christina M. Kochel, Christopher J. Nirschl, Nicholas M. Durham, Jacob Ruzevick, Angela Alme, Brian J. Francica, Jimmy Elias, Andrew Daniels, Thomas W. DubenskyJrJr, Peter Lauer, Dirk G. Brockstedt, Emily G. Baxi, Peter A. Calabresi, Janis M. Taube, Carlos A. Pardo, Henry Brem, Drew M. Pardoll, Michael Lim & Charles G. Drake. (2016) Systemic Tolerance Mediated by Melanoma Brain Tumors Is Reversible by Radiotherapy and Vaccination. Clinical Cancer Research 22:5, pages 1161-1172.
Crossref
Aaron T. Wild, Joseph M. Herman, Avani S. Dholakia, Shalini Moningi, Yao Lu, Lauren M. Rosati, Amy Hacker-Prietz, Ryan K. Assadi, Ali M. Saeed, Timothy M. Pawlik, Elizabeth M. Jaffee, Daniel A. Laheru, Phuoc T. Tran, Matthew J. Weiss, Christopher L. Wolfgang, Eric Ford, Stuart A. Grossman, Xiaobu Ye & Susannah G. Ellsworth. (2016) Lymphocyte-Sparing Effect of Stereotactic Body Radiation Therapy in Patients With Unresectable Pancreatic Cancer. International Journal of Radiation Oncology*Biology*Physics 94:3, pages 571-579.
Crossref
Adela Wu & Michael Lim. (2016) Issues to Consider in Designing Immunotherapy Clinical Trials for Glioblastoma Management. Journal of Cancer Therapy 07:08, pages 573-585.
Crossref
Emily S. Wu, Titilope Oduyebo, Lauren P. Cobb, Diana Cholakian, Xiangrong Kong, Amanda N. Fader, Kimberly L. Levinson, Edward J. TannerIIIIII, Rebecca L. Stone, Anna Piotrowski, Stuart Grossman & Kara Long Roche. (2016) Lymphopenia and its association with survival in patients with locally advanced cervical cancer. Gynecologic Oncology 140:1, pages 76-82.
Crossref
Susannah Ellsworth & Stuart A Grossman. (2015) Comment on ‘Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma’. British Journal of Cancer 113:11, pages 1632-1633.
Crossref
David A. Reardon, Mark R. Gilbert, Wolfgang Wick & Linda Liau. (2015) Immunotherapy for neuro-oncology: the critical rationale for combinatorial therapy. Neuro-Oncology 17:suppl 7, pages vii32-vii40.
Crossref
Vaishali Kapoor, Arpine Khudanyan, Pilar de la Puente, Jian Campian, Dennis E. Hallahan, Abdel Kareem Azab & Dinesh Thotala. (2015) Stem Cell Transfusion Restores Immune Function in Radiation-Induced Lymphopenic C57BL/6 Mice. Cancer Research 75:17, pages 3442-3445.
Crossref
Jian L. Campian, Xiaobu Ye, Douglas E. Gladstone, Prakash Ambady, Thomas R. Nirschl, Ivan Borrello, Marc Golightly, Karen E. King, Matthias Holdhoff, Judith Karp, Charles G. Drake & Stuart A. Grossman. (2015) Pre-radiation lymphocyte harvesting and post-radiation reinfusion in patients with newly diagnosed high grade gliomas. Journal of Neuro-Oncology 124:2, pages 307-316.
Crossref
Mi Zhou, Paige M. Bracci, Lucie S. McCoy, George Hsuang, Joseph L. Wiemels, Terri Rice, Shichun Zheng, Karl T. Kelsey, Margaret R. Wrensch & John K. Wiencke. (2015) Serum macrophage-derived chemokine/CCL22 levels are associated with glioma risk, CD4 T cell lymphopenia and survival time. International Journal of Cancer 137:4, pages 826-836.
Crossref
Peiwen Kuo, Scott V. Bratman, David B. Shultz, Rie von Eyben, Cato Chan, Ziwei Wang, Carmen Say, Aparna Gupta, Bill W. LooJrJr, Amato J. Giaccia, Albert C. Koong, Maximilian Diehn & Quynh-Thu Le. (2014) Galectin-1 Mediates Radiation-Related Lymphopenia and Attenuates NSCLC Radiation Response. Clinical Cancer Research 20:21, pages 5558-5569.
Crossref
Yaacov Richard Lawrence & Adam P Dicker. (2014) Radiation therapy and the immune system: learning to live together. Future Oncology 10:5, pages 777-780.
Crossref